First example of multicomponent synthesis of 1-ethoxy-3-(4-aryl)-1-phenyl-1H-benzo[f]chromene derivatives
-
Add time:08/28/2019 Source:sciencedirect.com
A new series of 1-ethoxy-3-(4-aryl)-1-phenyl-1H-benzo[f]chromenes have been synthesized efficiently. The procedure involves the multicomponent reaction of 2-naphthol, acetophenone derivatives, and triethyl orthobenzoate catalyzing by efficient bis(2-anilinotropone) Ti complex.
We also recommend Trading Suppliers and Manufacturers of 4-(4-ETHOXY-PHENYL)-5-PYRIDIN-3-YL-4H-[1,2,4]TRIAZOLE-3-THIOL (cas 111114-78-4). Pls Click Website Link as below: cas 111114-78-4 suppliers
Prev:N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity
Next:Synthesis, cytotoxicity and DNA-binding properties of Pd(II), Cu(II) and Zn(II) complexes with 4′-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-2,2′:6′,2″-terpyridine) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Data articleSynthesis, characterization and crystal structure of 4-[(6-ethoxy benzothiazol-2-yl) diazenyl] phenyl 2-(2, 3-dihydro-1H-inden-2-yl) acetate09/02/2019
- SYNTHESIS AND PROPERTIES OF POLYIMIDES DERIVED FROM 2,2-BIS[4-[2-(4-AMINOPHENOXY)ETHOXY]PHENYL]PROPANE09/01/2019
- Original articleSynthesis and antimicrobial studies of a new series of 2-{4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}-5-substituted-1,3,4-oxadiazoles08/31/2019
- Synthesis and pharmacological evaluation of substituted 5-[4-[2-(6,7-dimethyl-1,2,3,4-tetrahydro-2-oxo-4-quinoxalinyl)ethoxy]phenyl]methylene]thiazolidine-2,4-dione derivatives as potent euglycemic and hypolipidemic agents08/30/2019
- Synthesis, cytotoxicity and DNA-binding properties of Pd(II), Cu(II) and Zn(II) complexes with 4′-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-2,2′:6′,2″-terpyridine08/29/2019
- N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity08/27/2019
- Synthesis, in vitro and in vivo evaluation of novel substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines as potent antitumor agents08/26/2019
